Liver transplantation for primary biliary cirrhosis
Research output: Contribution to journal › Review article
Colleges, School and Institutes
Liver transplantation is now the accepted treatment for patients with end-stage disease or intractable symptoms. The success rate is high. Those grafted for PBC are at greater risk of developing acute and chronic rejection and are less likely to be weaned from immunosuppression. Following transplantation, AMA persist and histological features of PBC may be seen in the allograft, in up to 50% by 10 years.
|Number of pages||7|
|Publication status||Published - 1 Jan 2003|